Robert Cunningham - 15 Mar 2024 Form 4 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role
Director
Signature
/s/ Robert Cunningham
Issuer symbol
AXIM
Transactions as of
15 Mar 2024
Net transactions value
+$1,225,000,000
Form type
4
Filing time
19 Mar 2024, 19:33:59 UTC
Previous filing
23 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXIM Convertible Note Award $1,225,000,000 +35,000 +0.78% $35000.00* 4,500,000 15 Mar 2024 Common Stock 3,500,000 $0.0100 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person acquired a Convertible Note, face value $35,000. The Note is convertible into shares of the Issuer's common stock at a price of $0.01 per share.